Firefly Says Its BNA System Offers Scalable Solution For Early Alzheimer's Diagnosis

(RTTNews) - Firefly Neuroscience (AIFF), an AI company focused on improving brain health outcomes, announced on Tuesday, a major research breakthrough in estimating the biological age of the brain using its FDA-cleared BNA technology platform.

The BNA system makes use of the Resting EEG and Cognitive EEG data to assess patients' brain age. This approach is capable of finding a significant disparity between brain age and chronological age, which may be an important risk factor for dementia.

Using EEG to measure brain age could enable a proactive and scalable method for early screening of Alzheimer's patients, according to the company.

As of September 30, 2024, the company had cash totaling $1.2 million.

Currently, AIFF is trading at $4.58, up by 140%